Navigation Links
Mylan Launches Generic Lipitor® in Five European Countries
Date:5/11/2012

PITTSBURGH and LYON, France, May 11, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg in France, Belgium, the UK, the Netherlands and Ireland. Mylan has received marketing authorization from each country's respective health authority to begin selling its product immediately. Atorvastatin Calcium is the generic version of Pfizer's Lipitor® Tablets. This product is indicated for the prevention of cardiovascular disease and hypercholesterolemia.

Mylan CEO Heather Bresch said: "We are pleased to provide access to generic Lipitor to more than 4 million patients in five countries across Europe. Mylan is committed to expanding access to high quality medicine in Europe and around the world. Mylan's launch of Atorvastatin Calcium Tablets will help to provide health care systems in these markets with an estimated $700 million (euro 500 million) of savings in 2012 associated with the generic availability of this important medicine."

In France, Belgium, the UK, the Netherlands and Ireland, Lipitor had total sales of $1.6 billion (euro 1.126 billion) for the twelve months ending Dec. 31, 2011, according to IMS Health.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately one-third of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 150 countries and territories. Our workforce of more than 18,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
2. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
3. Mylan Launches Generic Version of Zyprexa® Tablets
4. Mylan Launches First Generic Version of Lescol® Capsules
5. Mylan Schedules First Quarter 2012 Financial Results Conference Call and Live Webcast
6. Mylan One of First to Launch Generic Version of Boniva®
7. Mylan Canada Receives Health Canada Approval for Generic Version of Crestor®
8. Mylan Continues to Pursue Damages and Injunction Against Sunovions Brovana® in Ongoing Litigation
9. Mylan Pharmaceuticals President Tony Mauro Elected Chairman of GPhA
10. Mylan Secures an Additional $300 Million of Committed Financing
11. Mylan Reports Adjusted Diluted EPS of $0.53 for the Quarter, an 18% Increase Over Prior Year Quarter; and $2.04 for the Year, a 27% Increase Over Prior Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2019)... ... 2019 , ... Houston Methodist has pledged $2 million to ... The hospital system’s support gift was announced today during a traditional topping ... building’s frame and celebrate the significant milestone. , During the event, a ...
(Date:6/20/2019)... ... June 20, 2019 , ... LuckyVitamin, an e-commerce specialty ... Philadelphia Business Journal’s Healthiest Employers of 2019. LuckyVitamin’s Founder and Chief Wellness Spreader, ... during a ceremony at the Ballroom at the Ben on June 13, 2019. ...
(Date:6/19/2019)... ... June 19, 2019 , ... Cardiovascular diseases ... percent of all global deaths (17.9 million per year), and are the most ... to make care pathways, treatment and real-time visualization of cardiac anomalies and subsequent ...
Breaking Medicine Technology:
(Date:6/24/2019)... Pa. (PRWEB) , ... June 24, 2019 , ... ... for adolescents and adults, today announced the restructuring of the Strategic Advisory Board ... struggling to meet the demand for behavioral health care. , We ...
(Date:6/20/2019)... (PRWEB) , ... June 20, 2019 , ... ... cycle management and IT services, announced that Angel Rosa has been appointed as ... leadership experience in developing and implementing new services, growing and nurturing high performing ...
(Date:6/20/2019)... ... June 20, 2019 , ... The 2019 Colorado Classic® presented by VF Corporation ... top-20 UCI women’s elite teams, organizers announced today. The top-four domestic teams in ... to the race. , The standalone pro women’s road race has received commitments ...
(Date:6/19/2019)... (PRWEB) , ... June 19, 2019 , ... CEO Steven ... the Top CEOs in 2019 . Glassdoor , one of the ... which highlights top leaders employees love working for in countries throughout North America and ...
(Date:6/19/2019)... LEXINGTON, Mass. (PRWEB) , ... June 19, 2019 ... ... its 26th annual International Research Congress (IRC) in Marseille, France. The ... dissemination of state-of-the-art research on facioscapulohumeral muscular dystrophy (FSHD). Nearly 200 researchers, clinicians, ...
Breaking Medicine News(10 mins):